Get the Stockscreener App
22.03
4.09%
-0.94
Pre-market:
22.43
0.40
+1.82%
ARK Genomic Revolution ETF stock is traded at $22.03, with a volume of 3.53M.
It is down -4.09% in the last 24 hours and down -20.35% over the past month.
The investment seeks long-term growth of capital.
The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.
See More
Previous Close:
$22.97
Open:
$22.95
24h Volume:
3.53M
Relative Volume:
1.05
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-5.12%
1M Performance:
-20.35%
6M Performance:
-15.66%
1Y Performance:
-25.42%
1-Day Range:
$21.82
$23.09
1-Week Range:
$21.56
$23.56
52-Week Range:
$21.56
$31.16
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
Name
ARK Genomic Revolution ETF
Sector
Industry
Phone
855-406-1506
Address
-
Compare ARKG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ARKG
ARK Genomic Revolution ETF
|
22.03 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
271.18 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
551.42 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
554.06 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
217.89 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
468.34 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF Stock (ARKG) Latest News
Cathie Wood Loads up on COIN and HOOD Stocks but Sells $13M Worth PATH Stock - Markets Insider
Cathie Wood's ARKK Attracts Cash Despite Big Losses - etf.com
Shares of ARKG Now Oversold - Nasdaq
Why Tempus AI (TEM) Shares Are Soaring: The Cathie Wood Effect - Yahoo Finance UK
Cathie Wood Capitalizes on Pullback in Tempus AI to Buy Additional Stock Worth $14.4M - TipRanks
Cathie Wood Smelling AI Opportunity? Ark Invest Buys Tempus AI Dip, Scoops Up Over $13 M Worth Of Stock - Benzinga
7 Best ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
Cathie Wood's Monday Moves: Ark Buys Tempus AI Dip And Airbnb Spike— Goes Shopping For Coinbase Stock Amid Trump Tariff Crypto Meltdown - Benzinga
Cathie Wood Loves This Under-the-Radar AI Stock. Is It Time for You to Buy Now? - The Globe and Mail
Cathie Wood Loves This Under-The-Radar AI Stock. Is It Time For You To Buy Now? - Barchart
(ARKG) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Cathie Wood's Ark Invest Loads Up On Tempus AI, Archer Aviation, But Sells Twist Bioscience: Here Are Key Ark Trades This Friday - Benzinga
Unusually active option classes on open February 28th - TipRanks
Sanctuary Advisors LLC Buys 1,288 Shares of Cambria Foreign Shareholder Yield ETF (BATS:FYLD) - Defense World
ARK Genomic Revolution ETF (BATS:ARKG) Shares Bought by Atria Wealth Solutions Inc. - Defense World
Tempus AI (TEM) Shares Continue Slide Despite Ark Invests Buy-on-the-Dip Efforts - Markets Insider
Interesting ARKG Put And Call Options For April 11th - Nasdaq
Cathie Wood bought the dip on Tempus AI, grabbing over 400K shares after a 15% drop - MSN
Ark Invest Buys the Dip as Cathie Wood Snaps Up Tempus AI Shares - GuruFocus.com
Cathie Wood Loads Up on Tempus AI Stock (TEM) - Markets Insider
Tempus AI Stock Has Soared 108% Already in 2025; Is It a Buy Now? - MSN
Ark Invest Shakes Up Portfolio with Strategic Moves Into AI and Crypto - Mi Valle
Cathie Wood's Buys The Dip In Tempus AI, Coinbase But Sells Ark's Bitcoin ETF Shares Amid Crypto Meltdown - Benzinga
Cathie Wood Buys The Dip In Tempus AI, Coinbase But Sells Ark's Bitcoin ETF Shares Amid Crypto Meltdown - Benzinga
Rocket Lab, Kratos, Archer Aviation And More Earnings This Week Could Have A Big Impact On Cathie Wood's Ark ETFs - Benzinga
Cathie Wood’s Ark ETFs Are in Freefall as Tech Selloff Resumes - Wealth Management
NIH Funding Cuts To Spook Healthcare Stocks? RFK Jr's Confirmation At HHS Sparks Concerns Over Research Dollars, 'Causing Uncertainty,' Says Analyst - Benzinga
Cathie Wood's Ark Invest Loads Up On Beam Therapeutics, Nu Holdings: Offloads MercadoLibre, Adaptive BiotechnologiesARK Fintech Innovation ETF (ARCA:ARKF), Adaptive Biotechnologies (NASDAQ:ADPT) - Benzinga
(ARKG) On The My Stocks Page - Stock Traders Daily
ARK Invest Europe Prepares to Close Rize Digital Payments ETF - Yahoo Finance
ARK ETF Adjusts Portfolio With Key Investments - Evrim Ağacı
Cathie Wood’s ARK ETF adjusts portfolio with key stock trades - Investing.com India
Cathie Wood’s ARK ETF adjusts portfolio with key stock trades By Investing.com - Investing.com Australia
Cathie Wood's ARK ETF adjusts portfolio with key stock trades - Investing.com
Cathie Wood's ARK ETF adjusts portfolio with key stock trades By Investing.com - Investing.com UK
Best-Performing ETFs of Last Week - Yahoo Finance
Unusually active option classes on open February 18th - TipRanks
Cathie Wood's Ark Invest Loads Up On Iridium, Twist Bioscience, Offloads Roku: Here Are Key Ark Trades This Friday - Benzinga
Ark Invest Stock Price - IndexBox, Inc.
Cathie Wood goes all in on Tempus AI, boosting holdings by over 600K shares in 2025 - MSN
When (ARKG) Moves Investors should Listen - Stock Traders Daily
Tempus AI Executives Sell $20 Million In Stock As Cathie Wood Buys And Nancy Pelosi Eyes Options - Benzinga
Cathie Wood Sours on Tesla and Moderna, but Likes These Stocks Instead - 24/7 Wall St.
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday - Benzinga
Big Ideas 2025: Cathie Wood highlights converging forces in AI - Seeking Alpha
ARK Genomic Revolution ETF Stock (ARKG) Financials Data
There is no financial data for ARK Genomic Revolution ETF (ARKG). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.51%
Cap:
|
Volume (24h):